Related Experiment Videos
Treating depressed and anxious smokers in smoking cessation programs
C Steven Richards1, Lee M Cohen, Holly E R Morrell
1Department of Psychology, Texas Tech University, Lubbock, TX 79409-2051, USA. steven.richards@ttu.edu
Journal of Consulting and Clinical Psychology
|March 21, 2012
Summary
Treating depressed and anxious smokers is challenging but crucial. Evidence-based, multidisciplinary smoking cessation programs offer significant health benefits for these individuals.
Area of Science:
- Public Health
- Behavioral Science
- Clinical Psychology
Background:
- Cigarette smoking is a leading cause of preventable death.
- Smokers with depression and anxiety exhibit higher smoking rates.
- Effective treatment for this population is complicated by emotional dysregulation and barriers.
Purpose of the Study:
- To review literature on treating smokers with comorbid depression and anxiety.
- To discuss challenges and guidelines for smoking cessation in this population.
- To highlight the need for focused interventions on both disorders.
Main Methods:
- Literature review of smoking cessation programs.
- Discussion of treatment issues and challenges.
- Examination of guidelines for effective interventions.
Main Results:
- Potential for significant health and functional improvements.
- Compelling merit for evidence-based interventions.
- Need for practical, multidisciplinary, cost-effective programs.
Conclusions:
- Urgent need for an aggressive public health approach.
- Current timing is optimal for health promotion efforts.
- Focusing on comorbid depression and anxiety is essential.
Related Concept Videos
Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Behavior Therapy
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...